Skip to main content

Table 2 Underlying malignancies, operation methods, pathological findings, treatment alterations, and outcomes

From: The utility of surgical lung biopsy in cancer patients with acute respiratory distress syndrome

Patient

Underlying malignancies

Operation methods

Pathological findings

Treatment alterations

Outcome

1

AML, M2 types

thoracotomy

Acute leukemia with lung involvement

chemotherapy

Deceased

2

Diffuse large B cell lymphoma, stage IVB

thoracotomy

Interstitial pneumonitis; Pneumocystis jiroveci infection

cotrimoxazole

Survival

3

CML, post BMT

thoracotomy

DAD; Pneumocystis jiroveci infection

cotrimoxazole

Deceased

4

NSCLC, stage IIIb

thoracotomy

Intersitial pneumonitis with fibrosis

No

Deceased

5

ALL, post BMT

VATS

DAD, Aspergillosis infection

No

Deceased

6

NSCLC, stage IV

VATS

DAD; metastatic adenocarcinoma

corticosteroids and stop antibiotics

Survival

7

ALL

VATS

Desquamative interstitial pneumonitis

corticosteroids

Survival

8

Breast cancer,

thoracotomy

Interstitial pneumonitis with fibrosis

no

Survival

9

NSCLC, stage IV

thoracotomy

DAD, acute and organizing phase

corticosteroids and stop antibiotics

Survival

10

AML, M4 types

thoracotomy

Bronchopneumonia with organizing change

no

Survival

11

NSCLC, stage IV

VATS

Interstitial pneumonitis with organizing change

corticosteroids

Survival

12

Mantle cell lymphoma stage IVa

VATS

DAD, acute and organizing phase; viral inclusion bodies

corticosteroids and stop antibiotics

Survival

13

NHL, stage IVB

thoracotomy

DAD; Pneumocystis jiroveci infection

no

Deceased

14

SCLC, limited stage

VATS

DAD, acute and organizing phase

stop anti-tuberculosis agent

Deceased

15

Mantle cell lymphoma, stage IIIA

thoracotomy

Acute fibrosis and organizing pneumonia

corticosteroids and stop antibiotics

Survival

16

Diffuse large B cell lymphoma, stage IVA

VATS

DAD, acute and organizing phase

corticosteroids and stop antibiotics

Survival

  1. AML: acute myeloid leukemia; CML: chronic myeloid leukemia; DAD: diffuse alveolar damage; NSCLC: non-small cell lung cancer; ALL: acute lymphocytic leukemia; BMT: bone marrow transplantation; VATS: video-assisted thoracoscopic surgery; NHL: non-Hodgkin lymphoma; SCLC: small cell lung cancer.